IDP Pharma has closed a 1,4M€ seed investment round, following a pre-seed round of 0,1M€ (June 2015), which adds up to the ca 0,6M€ funds granted by several public institutions (MINECO, ENISA, CDTI-NEOTEC and ACCIÓ).

The company will allocate the capital to advance the preclinical development of its prioritized product – a first in class drug for multiple mieloma treatment, to set up new discovery programs, and to continue developing its technological platform.

Source: IDP Pharma

Subscribe to Directory
Write an Article

Highlight

Ardian crea el grupo MonBake tras cerrar...

by Ardian

Ardian, uno de los mayores fondos de inversión de Europa, cerró ayer...

La Bolsa Social, primera plataforma de i...

by La Bolsa Social

La Bolsa Social, primera plataforma de inversión participativa aproba...

Photos Stream